When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYL - Gilead inks deal to sell remdesivir in 127 countries
Mylan N.V.
Gilead Sciences (GILD-1.2%) has out-licensed non-exclusive rights to antiviral remdesivir to India's Jubilant Life Sciences allowing the latter to sell the drug in 127 countries including India.
More news on: Gilead Sciences, Inc., Mylan N.V., Healthcare stocks news,